Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 Dicembre 2021 News Human COVID-19 Vaccines EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 Dicembre 2021 News Human COVID-19 Medicines International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 Dicembre 2021 News Human COVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 Dicembre 2021 News Veterinary Maximum residue limit Medicines International regulators stress continued need for COVID-19 therapeutics 10 Dicembre 2021 News Human COVID-19 Medicines EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 Dicembre 2021 News Human COVID-19 Vaccines ICMRA high-level meeting on global health emergencies and regulatory approaches 6 Dicembre 2021 News Human COVID-19 Medicines Vaccines EMA recommends approval for use of RoActemra in adults with severe COVID-19 6 Dicembre 2021 News Human COVID-19 Medicines ICMRA and WHO map out flexibilities used by regulators to respond to the COVID-19 pandemic 3 Dicembre 2021 News Human COVID-19 Medicines Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021 3 Dicembre 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines 1 … 48 49 50 51 52 Page 52 of 379 53 54 55 56 … 379
COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 Dicembre 2021 News Human COVID-19 Vaccines
EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 Dicembre 2021 News Human COVID-19 Medicines
International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 Dicembre 2021 News Human COVID-19
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 Dicembre 2021 News Veterinary Maximum residue limit Medicines
International regulators stress continued need for COVID-19 therapeutics 10 Dicembre 2021 News Human COVID-19 Medicines
EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 Dicembre 2021 News Human COVID-19 Vaccines
ICMRA high-level meeting on global health emergencies and regulatory approaches 6 Dicembre 2021 News Human COVID-19 Medicines Vaccines
EMA recommends approval for use of RoActemra in adults with severe COVID-19 6 Dicembre 2021 News Human COVID-19 Medicines
ICMRA and WHO map out flexibilities used by regulators to respond to the COVID-19 pandemic 3 Dicembre 2021 News Human COVID-19 Medicines Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021 3 Dicembre 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines